Personalized Cell Replacement for Parkinson’s

Warren Peters,  MD,  MPH,  FOMADirector – Metabolic Obesity Research Clinic (MORC)Associate Professor LOMA LINDA UNIVERSITY – School of Public Health From Dopamine Pills to Personalized Neurons: Aspen’s Autologous Cell Therapy for Parkinson’s Disease Parkinson’s disease (PD) has long been managed through pharmacology: levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors, and complex delivery systems designed to… Continue reading Personalized Cell Replacement for Parkinson’s

Exit mobile version